PDA (Pentadeca Arginate) is a niche research peptide with two things a buyer should understand up front: it has no studies of its own — its reputation is entirely inherited from BPC-157, and the products are lightly regulated. That combination makes COA quality the single most important purchase factor — more than price, and more than any "upgraded BPC-157" marketing. This guide teaches you how to evaluate any PDA vendor; it pairs with our PDA dosing guide and reconstitution guide.
This is not a ranked vendor list — for that, see our Best PDA Vendors comparison. This guide teaches you how to evaluate any vendor yourself.
Research-context information only. PDA (pentadeca arginate) is an unapproved research compound not evaluated by the FDA. There is no PDA-specific human evidence; its claims are extrapolated from BPC-157. This article reports how it is sold, not medical or legal advice. Consult a licensed physician for personal medical decisions.
Understanding PDA Pricing
PDA is the arginate-salt form of the BPC-157 peptide — short and well-characterized to synthesize — and it is sold mainly as 10 mg lyophilized vials. Pricing tends to sit close to BPC-157, sometimes carrying a small premium tied to the "more stable" marketing.
Current Market Pricing (2026)
| Vial Size | Typical Price Range | Price Per mg | Best For |
|---|---|---|---|
| 10 mg | $44 - $49 | ~$4.40 - $4.90/mg | The common format; covers a full short course |
The pattern: PDA is sold almost exclusively as 10 mg. Because community doses are small, even a single 10 mg vial holds many doses — so the practical question is how much you'll use within ~28 days of reconstituting, not how many vials a course needs. Do not pay a large premium over BPC-157 expecting a stronger effect; no evidence supports one.
Cost Per Course at Community Doses
There is no PDA-specific trial dose, so this is illustrative using common community figures (borrowed from BPC-157). A 10 mg vial at a 250 mcg/day community dose covers ~40 days.
| Community dose | Days per 10 mg vial | Vials per 6-week course |
|---|---|---|
| 250 mcg/day | ~40 days | ~1 |
| 500 mcg/day | ~20 days | ~2 |
| 500 mcg twice daily | ~10 days | ~4 |
For current vendor-specific pricing with exact $/mg breakdowns, see our Best PDA Vendors comparison.
How to Verify PDA Quality
PDA is a short peptide whose lyophilized powder looks identical regardless of purity, salt form, or even identity. With a niche compound, limited oversight, and aggressive "upgraded BPC-157" marketing, the COA is the only reliable check — and arguably matters more here than for mainstream peptides.
What a COA (Certificate of Analysis) Should Include
Identity Confirmation
- Mass spectrometry confirming the molecular weight expected for the BPC-157 sequence
- Amino acid sequence verification
Purity Testing
- HPLC purity — look for 98%+ (ideally 99%+) purity
- HPLC chromatogram showing a single dominant peak
Contamination Testing
- Endotoxin levels (bacterial contamination)
- Residual solvent analysis
- Heavy metals screening
How to Verify a COA Is Legitimate
- Check that the COA lists the specific product and a batch/lot number — not a generic template.
- Confirm the lot number on the COA matches the vial you receive.
- Look for a named third-party lab, not just an in-house claim.
- Cross-check the test date — a COA should be recent, not years old.
- Be wary if the vendor cannot produce a COA for the exact lot on request.
Red Flags to Avoid
- No COA available, or only a years-old generic one
- COA lot number that doesn't match the shipped vial
- Purity claims with no HPLC chromatogram attached
- A vendor making strong human efficacy or "clinically proven" claims for PDA — there are no PDA studies to support them
- "1,000x more stable than BPC-157" or similar marketing presented as if it were tested data
- No batch traceability, or a vendor unwilling to answer testing questions
